Sanjin ZvonićVP Process Science and Manufacturing at WindMIL Therapeutics, USA
Dr. Zvonić leads the late-stage development of WindMIL’s core technologies and pipeline products, as well as its manufacturing capabilities.
After earning his Doctorate in Cell and Molecular Biology, Dr. Zvonić took multiple academic post-doctoral positions where he worked on the development of methodologies for the isolation, expansion, and utilization of cell-based products. Following, he joined PCT, a renowned CMO, where he focused on client engagement and technology transfer, gaining a comprehensive understanding of cell therapy development, manufacturing, and commercialization strategies. He also worked at Novartis CGTU, where he focused on the development and commercialization of cell therapy products, including Kymriah.